Cart
sales@molnova.com
Ganoderic acid G
CAS No. 98665-22-6
Ganoderic acid G( —— )
Catalog No. M19843 CAS No. 98665-22-6
Ganoderic acid G is a highly oxidized lanostane-type triterpenoid from the fungus ganoderma lucidum.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 221 | In Stock |
|
| 5MG | 169 | In Stock |
|
| 10MG | 268 | In Stock |
|
| 25MG | 451 | In Stock |
|
| 50MG | 646 | In Stock |
|
| 100MG | 919 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGanoderic acid G
-
NoteResearch use only, not for human use.
-
Brief DescriptionGanoderic acid G is a highly oxidized lanostane-type triterpenoid from the fungus ganoderma lucidum.
-
DescriptionGanoderic acid G is a highly oxidized lanostane-type triterpenoid from the fungus ganoderma lucidum.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number98665-22-6
-
Formula Weight532.67
-
Molecular FormulaC30H44O8
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[C@H](CC(=O)CC(C)C(O)=O)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)[C@@H](O)[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1C[C@@H]3O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ganoderic acid G and I and ganolucidic acid A and B new triterpenoids from Ganoderma lucidum.
molnova catalog
related products
-
BV02
BV02 is an inhibitor of 14-3-3 protein-protein interactions and can be used in studies about the treatment of chronic myeloid leukemia. BV02 disrupts hematopoietic cells expressing the IM-resistant T315I mutation and the IM-sensitive wild-type Bcr-Abl.
-
Fructo-oligosacchari...
Fructo-oligosaccharide DP8 / GF7 belongs to fructooligosaccharides (FOS) with degree of polymerization (DP=8).?
-
Cannabidivarin
Cannabidivarin is a potent inhibitor against gamma 2 subunit of GABAA receptors. it may serve as a novel drug with definite control over childhood absence epilepsy.
